Abstract
While the imaging modality of choice to diagnose neurosarcoidosis is gadolinium-enhanced MRI, F-FDG PET/CT maybe used to stage the disease or target the optimal biopsy site. Few cases have described intense F-FDG uptake at the sites of active neurosarcoidosis in the midbrain and pituitary gland, cerebellar hemispheres, and temporal lobes. Here, we present a case of neurosarcoidosis whose PET/CT examination demonstrated F-FDG avidity in a dural plaque.
Original language | English (US) |
---|---|
Pages (from-to) | e410-e411 |
Journal | Clinical nuclear medicine |
Volume | 41 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1 2016 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging